Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stroke

Are antihypertensives beneficial in acute stroke?

Nature Reviews Neurology volume 7, pages 367–368 (2011)Cite this article

Subjects

Increased blood pressure is associated with poor outcomes in acute stroke, but studies assessing the use of antihypertensive agents have been inconclusive. The recent SCAST trial has found that the angiotensin receptor blocker candesartan does not benefit patients with acute stroke and elevated blood pressure, and might even be harmful.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Adams, H. P. et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38, 1655–1711 (2007).

    Article  Google Scholar 

  2. Oliveira-Filho, J. et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 61, 1047–1051 (2003).

    Article  CAS  Google Scholar 

  3. Sandset, E. C. et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377, 741–750 (2011).

    Article  CAS  Google Scholar 

  4. Schrader, J. et al. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34, 1699–1703 (2003).

    Article  Google Scholar 

  5. Potter, J. F. et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHIPPS): a randomized, placebo-controlled, double-blind pilot trial. Lancet Neurol. 8, 48–56 (2009).

    Article  CAS  Google Scholar 

  6. Leonardi-Bee, J., Bath, P. M., Phillips, S. J. & Sandercock, P. A. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33, 1315–1320 (2002).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cerebrovascular Division of the Department of Neurology, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, 21287, Maryland, USA

    Robert J. Wityk

Authors
  1. Robert J. Wityk
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wityk, R. Are antihypertensives beneficial in acute stroke?. Nat Rev Neurol 7, 367–368 (2011). https://doi.org/10.1038/nrneurol.2011.91

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.91

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing